×

Tag: IL-2

Lung cancer
Researchers have succeeded in beating a type of cancer previously considered incurable by using microcapsules that contained live cytokine-producing cells [1]. IL-2 is potent but toxic Interleukin-2 (IL-2) therapy was the first anti-cancer immunotherapy approved decades ago. It is based on the ability of this inflammatory cytokine to ramp up the body’s immune response to...

Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.

© 2025 Lifespan Research Institute – ALL RIGHTS RESERVED